China Defends COVID-19 Data-sharing as WHO Seeks More Access

FILED - 02 March 2024, China, Beijing: A medical service member takes a throat swab from a media representative of the People's Congress in China for a Covid-19 test. Photo: Johannes Neudecker/dpa
FILED - 02 March 2024, China, Beijing: A medical service member takes a throat swab from a media representative of the People's Congress in China for a Covid-19 test. Photo: Johannes Neudecker/dpa
TT

China Defends COVID-19 Data-sharing as WHO Seeks More Access

FILED - 02 March 2024, China, Beijing: A medical service member takes a throat swab from a media representative of the People's Congress in China for a Covid-19 test. Photo: Johannes Neudecker/dpa
FILED - 02 March 2024, China, Beijing: A medical service member takes a throat swab from a media representative of the People's Congress in China for a Covid-19 test. Photo: Johannes Neudecker/dpa

China has shared the most COVID-19 data and research results in the international community, its foreign ministry said on Tuesday, after the World Health Organization repeated its call for more information and access.
China is also the only country that organized experts to share traceability progress with the WHO on many occasions, Mao Ning, spokesperson at the foreign ministry, told a regular news conference.
In a statement on Monday, the WHO again asked China to share data and access to assist its efforts to understand the origins of COVID-19, the first cases of which were detected in central China five years ago.
According to the WHO, over 760 million COVID-19 cases and 6.9 million deaths have been recorded worldwide. In mid-2023, it declared an end to COVID-19 as a public health emergency but said the disease should be a permanent reminder of the potential for new viruses to emerge with devastating consequences.
Data from the early days of the pandemic was uploaded by Chinese scientists to an international database in early 2023, a few months after China dismantled all its COVID-19 restrictions and reopened its borders to the rest of the world, Reuters reported.
The data showed DNA from multiple animal species - including raccoon dogs - was present in environmental samples that tested positive for SARS-CoV-2, the virus that causes COVID, suggesting that they were "the most likely conduits" of the disease, according to a team of international researchers.
In 2021, a WHO-led team spent weeks in and around Wuhan - where the first cases were detected - and said the virus had probably been transmitted from bats to humans through another animal but further research was needed.
China had said no more visits were necessary and that the search of early cases should be conducted in other countries.
"On the issue of COVID-19 traceability, China has shared the most data and research results and made the greatest contribution to global traceability research," Mao said.



China Discovers Cluster of New Mpox Strain

A woman walks on the Youyi Bridge at the Liangmahe river in Beijing, China on Thursday, Jan. 9, 2025. (AP Photo/Aaron Favila)
A woman walks on the Youyi Bridge at the Liangmahe river in Beijing, China on Thursday, Jan. 9, 2025. (AP Photo/Aaron Favila)
TT

China Discovers Cluster of New Mpox Strain

A woman walks on the Youyi Bridge at the Liangmahe river in Beijing, China on Thursday, Jan. 9, 2025. (AP Photo/Aaron Favila)
A woman walks on the Youyi Bridge at the Liangmahe river in Beijing, China on Thursday, Jan. 9, 2025. (AP Photo/Aaron Favila)

Chinese health authorities said on Thursday they had detected the new mutated mpox strain clade Ib as the viral infection spreads to more countries after the World Health Organization declared a global public health emergency last year.
China's Center for Disease Control and Prevention said it had found a cluster outbreak of the Ib subclade that started with the infection a foreigner who has a history of travel and residence in the Democratic Republic of the Congo, Reuters reported.
Four further cases have been found in people infected after close contact with the foreigner. The patients' symptoms are mild and include skin rash and blisters.
Mpox spreads through close contact and causes flu-like symptoms and pus-filled lesions on the body. Although usually mild, it can be fatal in rare cases.
WHO last August declared mpox a global public health emergency for the second time in two years, following an outbreak in the Democratic Republic of Congo (DRC) that spread to neighboring countries.
The outbreak in DRC began with the spread of an endemic strain, known as clade I. But the clade Ib variant appears to spread more easily through routine close contact, including sexual contact.
The variant has spread from DRC to neighboring countries, including Burundi, Kenya, Rwanda and Uganda, triggering the emergency declaration from the WHO.
China said in August last year it would monitor people and goods entering the country for mpox.
The country's National Health Commission said mpox would be managed as a Category B infectious disease, enabling officials to take emergency measures such as restricting gatherings, suspending work and school, and sealing off areas when there is an outbreak of a disease.